(Q73473595)

English

Short-term treatment with interferon-alpha/beta promotes remyelination, whereas long-term treatment aggravates demyelination in a murine model of multiple sclerosis

scientific article published on 01 March 2000

Short-term treatment with interferon-?/? promotes remyelination, whereas long-term treatment aggravates demyelination in a murine model of multiple sclerosis

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686594%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Short-term treatment with interferon-alpha/beta promotes remyelination, whereas long-term treatment aggravates demyelination in a murine model of multiple sclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686594%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

multiple sclerosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Moses Rodriguez

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686594%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Njenga MK

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686594%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Coenen MJ

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686594%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

DeCuir N

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686594%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Yeh HY

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686594%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 March 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686594%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Journal of Neuroscience Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686594%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

59

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686594%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686594%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

661-670

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686594%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Interferon in experimental autoimmune encephalomyelitis (EAE): effects of exogeneous interferon on the antigen-enhanced adoptive transfer of EAE

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Enhanced wound healing in animal models by interferon and an interferon inducer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Interferons: pleiotropic cellular modulators

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Suppression of relapsing experimental autoimmune encephalomyelitis in the SJL/J mouse by oral administration of type I interferons

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type 1 interferons

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Clinical Trials with Exogenous Interferon: Summary of a Meeting

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Functional antagonism between type I and type II interferons on human macrophages

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

The induction of interferon production in fibroblasts by invasive bacteria: a comparison of Salmonella and Shigella species.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Contrasting effect of alpha/beta- and gamma-interferons on expression of macrophage Ia antigens

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

A brief history of the use of interferons as treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

VP1 and VP2 capsid proteins of Theiler's virus are targets of H-2D-restricted cytotoxic lymphocytes in the central nervous system of B10 mice

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Interferon inhibits the accumulation of glycerol phosphate dehydrogenase mRNA in oligodendrocytes and C6 cells.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Interferons and their actions

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Persistent infection of oligodendrocytes in Theiler's virus‐induced encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Immunosuppression promotes CNS remyelination in chronic virus‐induced demyelinating disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Inhibition of ornithine decarboxylase in human fibroblast cells by type I and type II interferons

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Induction of high titer chicken interferon

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Different pathogenicity of encephalitic togaviruses in organotypic cultures of spinal cord slices

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Clinical viral infections and multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Recent progress in interferon research: molecular mechanisms of regulation, action, and virus circumvention

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4547%2820000301%2959%3A5%3C661%3A%3AAID-JNR9%3E3.0.CO%3B2-E

21 January 2018

Identifiers

10.1002/(SICI)1097-4547(20000301)59:5<661::AID-JNR9>3.0.CO;2-E

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10686594%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73473595&oldid=1984621930"